IBB: Ishares Nasdaq Biotechnology Index Fund: Our expectations: Uptrend and a possible buy with target levels of about $ 350
Alternative scenario: Only a lower bottom or levels below 300 will lead to a change in our moods to short, so the longe remains more likely.
Comment: Upward movement with higher peaks and higher bottoms.
Correction to levels of diagonal support
Correction to Dynamic Support Levels 150 EMA
Еngalfing pattern at support levels - a strong bullish signal
CCI turns and probably will pass over -100, if it does, the long is very likely.
Stefan D. Angelov - Head of Stocks Trading
Read more:
25 Canada Square, Level 33, office 50, Canary Wharf London, E14 5LQ +44 20 3608 6256
World Financial Markets - 0700 17 600 Varchev Exchange - 0700 115 44
Varchev Finance Ltd is registered in the FCA (FINANCIAL CONDUCT AUTHORITY) with a passport in the United Kingdom: FCA, United Kingdom - registration number: 494 045, which allows provision of financial services in the United Kingdom.
Varchev Finance Ltd strictly comply with the statutes of the European directive MiFID (Markets in Financial Instruments). targeting increased efficiency, transparency and uniformity of financial instruments.
Varchev Finance Ltd is authorized and regulated by the Financial Supervision Commission - Sofia, Bulgaria: License number RG-03-02-05 / 15.03.2006
The information on this site is not intended for distribution or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.
Disclaimer:
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 63,41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.